Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :394
Small font sizeDefault font sizeIncrease font size
Navigate Here
 »   Next article
 »   Previous article
 »   Table of Contents

Resource Links
 »   Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »Related articles
 »   Citation Manager
 »   Access Statistics
 »   Reader Comments
 »   Email Alert *
 »   Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2623    
    Printed124    
    Emailed0    
    PDF Downloaded425    
    Comments [Add]    
    Cited by others 11    

Recommend this journal

 

 ORIGINAL ARTICLE
Year : 2008  |  Volume : 45  |  Issue : 4  |  Page : 154-157

Renal function in late survivors of Iranian children with cancer: Single centre experience


1 Department of Pediatric Hemat-Oncology, Ali Asgar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Department of Pediatric Nephrology, Ali Asgar Children's Hospital, Iran University of Medical Sciences, Tehran, Iran

Correspondence Address:
N Hooman
Department of Pediatric Nephrology, Ali Asgar Children's Hospital, Iran University of Medical Sciences, Tehran
Iran
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0019-509X.44663

Rights and Permissions

Context: One of the side-effects of chemotherapy is nephrotoxicity, whose incidence rate has reportedly been higher in pediatrics. Early diagnosis of renal dysfunction may decrease the morbidity in those with partial or complete remission by avoiding nephrotoxic agents and promoting regular follow-up. Aims: We studied the frequency of renal dysfunction in pediatric patients whose therapy was completed regardless of the type of chemotherapy. Settings and Design: Prospective cross sectional study in Hematoncology department of children's hospital. Materials and Methods:0 One hundred and eight pediatric cancer patients (44 females, 64 males), who were at least one year off therapy, enrolled in the study from 2003 to 2005. Demographic data, mean dosages of anticancer drugs, history of other nephrotoxic agents, nephrectomy, radiotherapy and acute renal failure were recorded. Fasting blood and urine samples were collected to calculate fractional excretion of magnesium, calcium, phosphate, urine protein to urine creatinine ratio, creatinine clearance (using Schwartz formula), urine analysis, urine osmolality and blood gas analysis. Statistical analysis used: T-test, Chi square and binary logistic regression were used to compare means, frequency and correlation respectively. P values < 0.05 were considered significant. Results: Renal dysfunction was seen in 25.2% of cases. These abnormalities included hypercalciuria (7.2%), phosphaturia (13.5%), magnesuria (3.6%), glomerular filtration rate less than 90 ml/min (7.5%), metabolic acidosis (3%), metabolic alkalosis (10%), urinary concentration defect (19%), proteinuria (7.2%), glycosuria (2%), microscopic hematuria (4%), sterile pyuria (6%), and hypertension (8%). We found only Procarbazin as an independent variable of nephrotoxicity (P<0.05). Conclusions: Mild to moderate tubular dysfunction has been observed in the survivors of cancer disease.






[FULL TEXT] [PDF]*


        
Print this article     Email this article

  Site Map | What's new | Copyright and Disclaimer
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow